Nicotine is primarily metabolized to cotinine in humans. In this study
, human cytochrome P450 (CYP) isoform involved in cotinine formation w
as identified. The formation of cotinine in 10 human liver microsomes
was determined with a 50 mu M nicotine concentration and with a cytoso
l preparation as a source of aldehyde oxidase. Cotinine formation in h
uman liver microsomes significantly correlated with immunochemically d
etermined CYP2A6 levels (r=0.663, p<0.05), coumarin 7-hydroxylase acti
vities (r=0.831, p<0.01), and cotinine 3'-hydroxylase activities (r=0.
735, p<0.01) that are responsible for CYP2A6. In inhibition studies, c
otinine formation in human liver microsomes was inhibited by coumarin
and rabbit anti-rat CYP2A1 antibody specifically. When the capability
of microsomes of B-lymphoblastoid cells expressing human CYPs to perfo
rm biotransformation of nicotine to cotinine was determined, cDNA-expr
essed CYP2A6 exhibited the highest cotinine formation. The K-Mapp valu
es from microsome expressing CYP2A6 cDNA were similar to the value obt
ained from human liver microsomes. The large interindividual variabili
ties in cotinine formation and immunochemically determined CYP2A6 leve
ls were observed in human liver microsomes, suggesting genetic polymor
phism of CYP2A6. Nicotine is a new in vivo probe for phenotyping of CY
P2A6 in humans.